Sinopulmonary Infections in Children
Sinopulmonary infections in children refer to bacterial or viral infections affecting both the paranasal sinuses and the lungs, occurring either concurrently or as complications of one another, and are particularly concerning in children with underlying immunodeficiency, cystic fibrosis, or ciliary dysfunction. 1, 2
Definition and Scope
Sinopulmonary infections encompass a spectrum of infectious diseases affecting the upper and lower respiratory tract simultaneously or sequentially:
The term specifically describes recurrent or chronic infections involving the sinuses (rhinosinusitis) and lungs (pneumonia, bronchitis, bronchiectasis) that occur together, particularly in children with underlying immune defects or structural abnormalities 1, 2
These infections are characterized by bacterial pathogens common to both anatomical sites, primarily Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in acute presentations 3, 4
In chronic or complicated cases, particularly in immunocompromised children, pathogens expand to include Staphylococcus aureus, Pseudomonas aeruginosa, and Burkholderia cepacia 1, 5
Clinical Presentations
Acute Bacterial Sinusitis
Acute bacterial sinusitis is defined by persistent illness with nasal discharge and/or daytime cough lasting >10 days without improvement, or a worsening course after initial viral upper respiratory infection symptoms 3, 6
Severe onset presentation includes concurrent fever ≥39°C with purulent nasal discharge for at least 3 consecutive days 3, 6
The diagnosis is clinical and does not require imaging in uncomplicated cases, as 87% of children with common colds show sinus abnormalities on imaging that resolve spontaneously 6
Community-Acquired Pneumonia
Pneumonia in children is defined as bronchopneumonia (primary involvement of airways and surrounding interstitium) or lobar pneumonia, with severity determined by respiratory distress and hypoxemia (SpO₂ <90% at sea level) 7
Complicated pneumonia includes parapneumonic effusions, multilobar disease, abscesses, necrotizing pneumonia, empyema, or pneumothorax 7
Children with moderate to severe CAP showing respiratory distress (tachypnea, retractions, nasal flaring, grunting) require hospitalization 7
High-Risk Populations
Immunodeficiency Disorders
Suspicion for sinopulmonary infections should be heightened in children with recurrent otitis media, bronchitis, and/or bronchiectasis, as 10% may have common variable immunodeficiency and 6% may have IgA deficiency 1
Hypogammaglobulinemia (IgG <5 g/L, IgA <0.1 g/L) predisposes to recurrent rhinosinusitis and bronchiectasis, and these patients may benefit from IV immunoglobulin replacement therapy 2
HIV-infected children are predisposed to sinopulmonary infections due to abnormal B-lymphocyte function 2
Cystic Fibrosis
Virtually all patients with CF have sinusitis due to dehydration of mucosal fluids and viscous secretions that predispose to bacterial infection 1
CF should be considered in any child with chronic sinusitis at an early age or in children with nasal polyps 1
Sinus pathogens in CF patients include P. aeruginosa, H. influenzae, streptococci, B. cepacia, S. aureus, and fungi 1
The sweat test (chloride >60 mEq/L in children) remains the gold standard for diagnosis, and should be performed in any child with nasal polyps or chronic Pseudomonas colonization 1
Primary Ciliary Dyskinesia
This autosomal-recessive disorder involves defective ciliary structure and function, leading to impaired mucus clearance and recurrent sinopulmonary infections 2
Microbiology and Resistance Patterns
Common Pathogens
In acute bacterial sinusitis, S. pneumoniae and H. influenzae each account for approximately 30% of cases, while M. catarrhalis accounts for approximately 10% 3
In chronic sinusitis in children ≤2 years old, bacterial cultures are positive in 100% of cases, with H. influenzae, S. pneumoniae, and B. catarrhalis being most common 4
In pleural empyema complicating pneumonia, S. pneumoniae is the predominant pathogen (75% of culture-negative cases by PCR), followed by S. aureus and S. pyogenes 5
Resistance Considerations
10-15% of upper respiratory tract isolates of S. pneumoniae are nonsusceptible to penicillin nationally, though values as high as 50-60% have been reported in some areas 3
Between 10-42% of H. influenzae and close to 100% of M. catarrhalis are β-lactamase positive and nonsusceptible to amoxicillin 3
Risk factors for resistant organisms include attendance at child care, receipt of antimicrobial treatment within the previous 30 days, and age younger than 2 years 3
In chronic sinusitis, 5 of 8 S. pneumoniae strains were relatively resistant to penicillin and resistant to trimethoprim-sulfamethoxazole, and all B. catarrhalis and 20% of H. influenzae were β-lactamase positive 4
Treatment Approach
First-Line Antibiotic Therapy
Amoxicillin remains the antimicrobial agent of choice for first-line treatment of uncomplicated acute bacterial sinusitis at 45 mg/kg/day in 2 divided doses 3, 8
In communities with high prevalence of nonsusceptible S. pneumoniae (>10%), or in children <2 years, daycare attendees, or recent antibiotic exposure, initiate high-dose amoxicillin at 80-90 mg/kg/day in 2 divided doses (maximum 2 g per dose) 3, 9
Amoxicillin-clavulanate provides broader coverage for β-lactamase-producing organisms and is preferred for frontal sinusitis or treatment failures 3, 9
Treatment Duration and Reassessment
Treat acute bacterial sinusitis for 10-14 days total, with a minimum of 10 days 3, 9
Reassessment is mandatory within 72 hours if symptoms worsen or fail to improve, and consideration should be given to changing to broader-spectrum antibiotics 3, 9
For children unlikely to be adherent or who have failed initial oral therapy, ceftriaxone 50 mg/kg (maximum 2 g) as a single IM or IV dose is indicated 10
Special Considerations for CF Patients
Younger children with CF not yet colonized with Pseudomonas should receive high-dose, prolonged courses (3-6 weeks) of amoxicillin-clavulanate, cefdinir, cefuroxime, or cefpodoxime 1
- Older children typically need coverage for P. aeruginosa with oral quinolones (ciprofloxacin, levofloxacin) or IV tobramycin, ceftazidime, or imipenem-meropenem for treatment failures 1
Critical Clinical Caveats
Bacterial sinusitis should not be diagnosed during the first week of viral URI symptoms, as viral rhinosinusitis causes sinus inflammation in 87% of patients with common colds, with most resolving spontaneously by days 13-20 11
Imaging studies should not be obtained for diagnosis of uncomplicated acute bacterial sinusitis, as they do not contribute to diagnosis and are reserved exclusively for suspected complications 6, 9
Complications requiring immediate imaging and specialist consultation include periorbital or orbital swelling with proptosis, impaired extraocular muscle function, severe headache with altered mental status, or signs of intracranial involvement 3, 9, 10
Infants <3-6 months of age with suspected bacterial pneumonia should be hospitalized due to increased risk of severe disease 7
When influenza is present concurrently with bacterial sinusitis, both oseltamivir and standard antibacterial treatment should be prescribed, as bacterial coinfection with influenza carries approximately 10% mortality in hospitalized patients 11
Trimethoprim-sulfamethoxazole and azithromycin should not be used for sinusitis due to high resistance rates 9, 12